Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Polymerase Chain Reaction (PCR) Market Be Worth By 2029?

The size of the polymerase chain reaction (pcr) market has experienced swift expansion in the past few years. There is expected growth from $11.42 billion in 2024, eventually reaching $12.57 billion in 2025, a reflection of a compound annual growth rate (CAGR) of 10.1%. The historical growth can be linked with the increase in research facilities, a rise in the number of patients suffering from chronic and infectious diseases, a growing occurrence of genetic and chronicle disorders, as well as population growth and a rising aging population.

The market size of the polymerase chain reaction (PCR) is projected to experience robust expansion in the upcoming years, reaching a value of $18.27 billion in 2029 with a compound annual growth rate (CAGR) of 9.8%. The upsurge in this projection period can be linked to the increased anxiety over food security, the escalating demand for secure and premium quality food items, the growing demand for molecular diagnostics, personalized medicinal demands, and the emphasis on digital Polymerase Chain Reaction (dPCR). Major tendencies during the forecast period incorporate real-time polymerase chain reaction, DNA sequencing technologies, advancements in diagnostic testing, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and progression in advanced molecular diagnostic solutions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15638&type=smp

What Market Forces Are Contributing To The Growth Of The Polymerase Chain Reaction (PCR) Market?

The expansion of the polymerase chain reaction (PCR) market is anticipated due to the escalated demand for personalized, or precision, medicine. Personalized medicine is a healthcare model that caters to each patient individually taking into account their unique characteristics for decisions, practices, interventions, and treatments. The interest in personalized medicine has seen a remarkable increase due to improved data analytics, medicines targeted to patient-specific responses, and the capability to customize therapies relying on one’s genetic makeup. The Polymerase Chain Reaction (PCR) plays a critical role in personalized medicine by allowing the magnification and examination of certain genetic segments, thereby assisting medical professionals in customizing care based on individual genetic outlines. Considering the data collected by the Personalized Medicine Coalition, an American professional membership organization, in 2022, the approval of 12 new personalized medicines accounted for almost 34% of all newly sanctioned therapies, suggesting a significant growth from the past years. Consequently, the growing preference for personalized medicine is propelling the upswing of the polymerase chain reaction market.

Which Segments Define The Structure Of The Polymerase Chain Reaction (PCR) Market?

The polymerase chain reaction (pcr)market covered in this report is segmented –

1) By Type: Conventional Polymerase Chain Reaction; Other Types

2) By Indication: Infectious Diseases; Oncology; Genetic Disorders; Other Indications

3) By Application: Medical; Non-Medical

4) By End User: Hospitals And Clinics; Pharmaceutical And Biotechnology Industries; Diagnostic Centers; Academic And Research Organization

Subsegments:

1) By Conventional Polymerase Chain Reaction: Endpoint Pcr; Gel Electrophoresis-Based Pcr; Reverse Transcription Pcr (Rt-Pcr); Quantitative Pcr (Qpcr) For Gene Expression; Nested Pcr

2) By Other Types: Real-Time Pcr (Qpcr) (Quantitative Pcr); Digital Pcr (Dpcr); Multiplex Pcr; Reverse Transcription-Quantitative Pcr (Rt-Qpcr); Isothermal Amplification (Lamp); Next-Generation Pcr (Ngs-Based Pcr Techniques); High-Throughput Pcr

What Strategic Shifts And Innovations Are Influencing The Polymerase Chain Reaction (PCR) Market?

In the polymerase chain reaction market, key players are focusing on the creation of real-time polymerase chain reaction test kits to bolster precision, efficiency, and user-friendliness in genetic testing. These laboratory-created RT-PCR test kits amplify and measure specific DNA sequences in real time. For instance, Cepheid, an American molecular diagnostics firm, introduced Xpert Xpress Multiplex Vaginal Panel (MVP) in November 2022. This FDA-approved multiplex PCR test is capable of identifying DNA linked to three separate vaginal infections – bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis – from a singular vaginal swab sample. This amplifies the functionalities of conventional polymerase chain reaction techniques with real-time tracking, quantification, and improved sensitivity and specificity, making it a critical instrument in both molecular biology and clinical diagnostics.

Which Firms Are Making The Biggest Impact In The Polymerase Chain Reaction (PCR) Market?

Major companies operating in the polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-global-market-report

Which Region Is Forecasted To Lead The Polymerase Chain Reaction (PCR) Market In The Coming Years?

North America was the largest region in the polymerase chain reaction (PCR) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15638&type=smp

Browse Through More Reports Similar to the Global Polymerase Chain Reaction (PCR) Market 2025, By The Business Research Company

Polymerase Chain Reactions Devices Reagents And Uses Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report

Blockchain Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blockchain-technologies-global-market-report

Blockchain Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blockchain-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model